CoChat

Adult Stem Cells and Diseases of Aging

Open access
Boyette, Lisa, Tuan, Rocky · 2014 · Journal of Clinical Medicine

The DOI matches its Crossref record; 293 of the 297 references it cites were found in a registry or an index.

Abstract

Preservation of adult stem cells pools is critical for maintaining tissue homeostasis into old age. Exhaustion of adult stem cell pools as a result of deranged metabolic signaling, premature senescence as a response to oncogenic insults to the somatic genome, and other causes contribute to tissue degeneration with age. Both progeria, an extreme example of early-onset aging, and heritable longevity have provided avenues to study regulation of the aging program and its impact on adult stem cell compartments. In this review, we discuss recent findings concerning the effects of aging on stem cells, contributions of stem cells to age-related pathologies, examples of signaling pathways at work in these processes, and lessons about cellular aging gleaned from the development and refinement of cellular reprogramming technologies. We highlight emerging therapeutic approaches to manipulation of key signaling pathways corrupting or exhausting adult stem cells, as well as other approaches targeted at maintaining robust stem cell pools to extend not only lifespan but healthspan.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/jcm3010088

Cites

293 of 293 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Environmental cues and evolutionarily conserved pathways that regulate the aging process in diverse eukaryotic phyla. Reprinted by permission from Macmillan Publishers Ltd.: Cell Death and Differentiation [86], copyright 2008.
Figure 1 Environmental cues and evolutionarily conserved pathways that regulate the aging process in diverse eukaryotic phyla. Reprinted by permission from Macmillan Publishers Ltd.: Cell Death and Differentiation [86], copyright 2008.CC BY · PubMed Central
Figure 2 (a) PTEN is active in quiescent long term-HSCs and represses protein kinase B (PKB) signaling towards downstream components (such as mTOR and FoxO). Active FoxO programs cells to remain quiescent by cell-cycle repression and other mechanisms, but also allows survival by switching to a metabolic program of gluconeogenesis and fatty acid metabolism, together with elimination of reactive oxygen species (ROS). Ataxia telangiectasia mutated (ATM) may function in conjunction with FoxO through an as yet undefined mechanism, probably involving regulation of ATM expression by FoxO. Proteins active in LT-HSCs are shown in white elipses; (b) HSCs are driven to proliferate after loss of PTEN or FoxO. PKB and other downstream phosphoinositide 3-kinase (PI(3)K) events are active in this situation (indicated in white elipses). Loss of FoxO results in increased intracellular ROS levels, which in turn activates p38. If PI(3)K signaling is required to drive LT-HSCs into proliferation under normal conditions, what external niche signals would do so are unknown. However, PI(3)K signaling may function in cooperation with other signaling pathways, and this is illustrated by c-Myc—a downstream target of Wnt signaling. Myc represses FoxO, and may also independently regulate control of proliferation; (c) Differentiation of lineage-restricted cells further continues and is guided by extracellular signals such as interleukins (ILs) and various colony stimulating factor (CSFs); (d) After executing their function, all hematopoietic cells die and regeneration begins. Modified with permission from Macmillan Publishers Ltd.: Nature Cell Biology [97], copyright 2007.
Figure 2 (a) PTEN is active in quiescent long term-HSCs and represses protein kinase B (PKB) signaling towards downstream components (such as mTOR and FoxO). Active FoxO programs cells to remain quiescent by cell-cycle repression and other mechanisms, but also allows survival by switching to a metabolic program of gluconeogenesis and fatty acid metabolism, together with elimination of reactive oxygen species (ROS). Ataxia telangiectasia mutated (ATM) may function in conjunction with FoxO through an as yet undefined mechanism, probably involving regulation of ATM expression by FoxO. Proteins active in LT-HSCs are shown in white elipses; (b) HSCs are driven to proliferate after loss of PTEN or FoxO. PKB and other downstream phosphoinositide 3-kinase (PI(3)K) events are active in this situation (indicated in white elipses). Loss of FoxO results in increased intracellular ROS levels, which in turn activates p38. If PI(3)K signaling is required to drive LT-HSCs into proliferation under normal conditions, what external niche signals would do so are unknown. However, PI(3)K signaling may function in cooperation with other signaling pathways, and this is illustrated by c-Myc—a downstream target of Wnt signaling. Myc represses FoxO, and may also independently regulate control of proliferation; (c) Differentiation of lineage-restricted cells further continues and is guided by extracellular signals such as interleukins (ILs) and various colony stimulating factor (CSFs); (d) After executing their function, all hematopoietic cells die and regeneration begins. Modified with permission from Macmillan Publishers Ltd.: Nature Cell Biology [97], copyright 2007.CC BY · PubMed Central
Figure 3 Roles of FoxO transcription factors in cells and in the organism. FoxO transcription factors trigger a variety of cellular processes by upregulating a series of target genes (in italics). The cellular responses elicited by FoxO affect a variety of organismal processes, including tumor suppression, longevity, development and metabolism. Reprinted by permission from Macmillan Publishers Ltd.: Oncogene [173], copyright 2008.
Figure 3 Roles of FoxO transcription factors in cells and in the organism. FoxO transcription factors trigger a variety of cellular processes by upregulating a series of target genes (in italics). The cellular responses elicited by FoxO affect a variety of organismal processes, including tumor suppression, longevity, development and metabolism. Reprinted by permission from Macmillan Publishers Ltd.: Oncogene [173], copyright 2008.CC BY · PubMed Central
Figure 4 The growth hormone (GH)—insulin-like growth factor I (IGF1) pathway and its signaling cascade, which involves PI(3)K and Akt, can modulate longevity and cancer in model systems. Calorific restriction inhibits GH-IGF1 signaling and can also inhibit mTOR and activate AMP-activated protein kinase (AMPK) and sirtuin 1 (SIRT1). Interactions between components of these pathways, and with SIRT1, remain incompletely understood. The role of SIRT1 in modulating mammalian ageing has not been demonstrated, and it seems to have a dual role in cancer. DNA repair systems and DNA damage checkpoints prevent the DNA damage accumulation that contributes to cancer and ageing, although possibly through different cellular mechanisms. Reprinted by permission from Macmillan Publishers Ltd.: Nature Reviews Cancer [264], copyright 2013.
Figure 4 The growth hormone (GH)—insulin-like growth factor I (IGF1) pathway and its signaling cascade, which involves PI(3)K and Akt, can modulate longevity and cancer in model systems. Calorific restriction inhibits GH-IGF1 signaling and can also inhibit mTOR and activate AMP-activated protein kinase (AMPK) and sirtuin 1 (SIRT1). Interactions between components of these pathways, and with SIRT1, remain incompletely understood. The role of SIRT1 in modulating mammalian ageing has not been demonstrated, and it seems to have a dual role in cancer. DNA repair systems and DNA damage checkpoints prevent the DNA damage accumulation that contributes to cancer and ageing, although possibly through different cellular mechanisms. Reprinted by permission from Macmillan Publishers Ltd.: Nature Reviews Cancer [264], copyright 2013.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 293 references

Research works printed but not linked: 2

  1. Geiger, 2009, Rat carcinogenicity study with gw501516, a ppar delta agonist, Toxicologist, 108, 185
  2. Newsholme, 2009, Mouse carcinogenicity study with gw501516, a ppar delta agonist, Toxicologist, 108, 185

Cited by

See all 111

Metadata

Authors
Boyette, L., & Tuan, R.
Affiliations
University of Pittsburgh (US)
Corresponding author
Tuan, Rocky
Venue
Journal of Clinical Medicine
Publisher
MDPI AG
Published
2014-01-21
Volume
3
Issue
1
Pages
88-134
ISSN
2077-0383 (ISSN-L)
OpenAlex
W2170769300
Cited by
108
References
297
Citations by year
2026: 4 · 2025: 10 · 2024: 3 · 2023: 4 · 2022: 13 · 2021: 12 · 2020: 11 · 2019: 9 · 2018: 10 · 2017: 9 · 2016: 11 · 2015: 8 · 2014: 4
FWCI
3.65
Type
journal article
Language
en
Open access
Locations
  • Journal of Clinical Medicine (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • D-Scholarship@Pitt (University of Pittsburgh) (acceptedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Pennsylvania Department of Health
  • National Institutes of Health
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases (Z01AR041131)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
Keywords
adult stem cells, aging, stem cell exhaustion, tissue homeostasis, cellular senescence, Hutchinson-Gilford progeria syndrome, age-related diseases, metabolic signaling, cellular reprogramming, lifespan extension, healthspan

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Adult Stem Cells and Diseases of Aging. https://app.cochat.ai/papers/10.3390/jcm3010088
The paper
Boyette, L., & Tuan, R. (2014). Adult Stem Cells and Diseases of Aging. Journal of Clinical Medicine. https://doi.org/10.3390/jcm3010088

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.